Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | ACACB | O00763 | 1/20 | 0.37 |
| ▸ | ACACA | Q13085 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21551881 | 1.00 | GPR84 (0.50) | GPR84FFAR4FFAR1NFKB1MGAM | |
| SCHEMBL21551850 | 1.00 | GPR84 (0.50) | GPR84FFAR4FFAR1NFKB1MGAM | |
| SCHEMBL1269210 | 0.91 | GPR84 (0.61) | GPR84FFAR4FFAR1NFKB1KMT2A | |
| SCHEMBL7599849 | 0.91 | GPR84 (0.61) | GPR84FFAR4FFAR1NFKB1KMT2A | |
| SCHEMBL12083744 | 0.91 | GPR84 (0.61) | GPR84FFAR4FFAR1NFKB1KMT2A | |
| SCHEMBL7598470 | 0.91 | GPR84 (0.61) | GPR84FFAR4FFAR1NFKB1KMT2A | |
| SCHEMBL7603423 | 0.91 | GPR84 (0.61) | GPR84FFAR4FFAR1NFKB1KMT2A | |
| SCHEMBL2310664 | 0.91 | GPR84 (0.61) | GPR84FFAR4FFAR1NFKB1KMT2A | |
| SCHEMBL22655388 | 0.91 | GPR84 (0.61) | GPR84FFAR4FFAR1NFKB1KMT2A | |
| SCHEMBL7602590 | 0.91 | GPR84 (0.61) | GPR84FFAR4FFAR1NFKB1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062720-A1 | Multifunctional Fatty Acid Derivatives And Biosynthesis Thereof | AGAIN BIO APS (DK) | 2026-03-05 | — | — | US | claimed |
| US-20240309405-A1 | MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF | OXFORD FINANCE LLC | 2024-09-19 | — | — | US | claimed |
| US-20210189439-A1 | Multifunctional Fatty Acid Derivatives And Biosynthesis Thereof | GENOMATICA, INC. (US) | 2021-06-24 | — | — | US | claimed |
| EP-3810778-A1 | MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF | Genomatica, Inc. (US) | 2021-04-28 | — | — | EP | claimed |
| WO-2019217226-A1 | MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF | REG Life Sciences, LLC (US) | 2019-11-14 | — | — | WO | claimed |
| US-20260062720-A1 | Multifunctional Fatty Acid Derivatives And Biosynthesis Thereof | AGAIN BIO APS (DK) | 2026-03-05 | — | — | US | disclosed |
| US-20240309405-A1 | MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF | OXFORD FINANCE LLC | 2024-09-19 | — | — | US | disclosed |
| US-20210189439-A1 | Multifunctional Fatty Acid Derivatives And Biosynthesis Thereof | GENOMATICA, INC. (US) | 2021-06-24 | — | — | US | disclosed |
| EP-3810778-A1 | MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF | Genomatica, Inc. (US) | 2021-04-28 | — | — | EP | disclosed |
| WO-2019217226-A1 | MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF | REG Life Sciences, LLC (US) | 2019-11-14 | — | — | WO | disclosed |
| WO-2019217226-A1 | MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF | REG Life Sciences, LLC (US) | 2019-11-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062720-A1 | Multifunctional Fatty Acid Derivatives And Biosynthesis Thereof | FASN, FFAR1, FFAR3 | GPR84 924/4885FFAR4 18/4885FFAR1 2/4885 |
| US-20240309405-A1 | MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF | DGAT2, DGAT1, FASN | GPR84 1380/4885FFAR4 76/4885FFAR1 31/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.